- Home
- OCX vs ACOG Comparison
OCX vs ACOG Comparison
Compare OCX & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- ACOG
- Stock Information
- Founded
- OCX 2009
- ACOG 2000
- Country
- OCX United States
- ACOG Canada
- Employees
- OCX N/A
- ACOG N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ACOG
- Sector
- OCX Health Care
- ACOG
- Exchange
- OCX Nasdaq
- ACOG Nasdaq
- Market Cap
- OCX 38.7M
- ACOG 32.4M
- IPO Year
- OCX N/A
- ACOG N/A
- Fundamental
- Price
- OCX $2.20
- ACOG $5.16
- Analyst Decision
- OCX Buy
- ACOG
- Analyst Count
- OCX 3
- ACOG 0
- Target Price
- OCX $4.42
- ACOG N/A
- AVG Volume (30 Days)
- OCX 112.4K
- ACOG 126.5K
- Earning Date
- OCX 11-12-2024
- ACOG 11-15-2024
- Dividend Yield
- OCX N/A
- ACOG N/A
- EPS Growth
- OCX N/A
- ACOG N/A
- EPS
- OCX N/A
- ACOG N/A
- Revenue
- OCX $709,000.00
- ACOG N/A
- Revenue This Year
- OCX N/A
- ACOG N/A
- Revenue Next Year
- OCX $106.34
- ACOG N/A
- P/E Ratio
- OCX N/A
- ACOG N/A
- Revenue Growth
- OCX N/A
- ACOG N/A
- 52 Week Low
- OCX $1.98
- ACOG $4.66
- 52 Week High
- OCX $3.82
- ACOG $7.00
- Technical
- Relative Strength Index (RSI)
- OCX 29.70
- ACOG N/A
- Support Level
- OCX $2.33
- ACOG N/A
- Resistance Level
- OCX $2.48
- ACOG N/A
- Average True Range (ATR)
- OCX 0.16
- ACOG 0.00
- MACD
- OCX -0.01
- ACOG 0.00
- Stochastic Oscillator
- OCX 39.29
- ACOG 0.00
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.